original ) (raw )Role of the TRAF Binding Site and NF-κB Activation in Epstein-Barr Virus Latent Membrane Protein 1-Induced Cell Gene Expression
George Mosialos
Journal of Virology
View PDFchevron_right
Epstein-Barr virus latent membrane protein 1 activation of NF- B through IRAK1 and TRAF6
George Mosialos
Proceedings of the National Academy of Sciences, 2003
View PDFchevron_right
Evidence of LMP1-TRAF3 interactions in glycosphingolipid-rich complexes of lymphoblastoid and nasopharyngeal carcinoma cells
Joëlle Wiels , Pierre Busson
International Journal of Cancer, 1999
View PDFchevron_right
Coupled transcription of Epstein--Barr virus latent membrane protein (LMP)-1 and LMP-2B genes in nasopharyngeal carcinomas
Gosta Winberg
Journal of General Virology, 1995
View PDFchevron_right
Expression of immune-related molecules in primary EBV positive chinese nasopharyngeal carcinoma: Associated with latent membrane protein 1 (LMP1) expression
Maria Masucci
Cancer Biology & Therapy, 2007
View PDFchevron_right
Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma
Valerie Salano
JCO Global Oncology
View PDFchevron_right
The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC)
Beckie Port
Seminars in Cancer Biology, 2012
View PDFchevron_right
Immunohistochemical expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1) in paraffin sections of EBV-associated nasopharyngeal carcinoma in Spanish patients
Javier Valera-Burgos
European Journal of Cancer Part B: Oral Oncology, 1996
View PDFchevron_right
Lack of cytotoxic property in a variant of Epstein–Barr virus latent membrane protein-1 isolated from nasopharyngeal carcinoma
Takeshi Nitta
Cellular Signalling, 2004
View PDFchevron_right
Role of the TRAF Binding Site and NF-kB Activation in Epstein-Barr Virus Latent Membrane Protein 1Induced Cell Gene Expression
George Mosialos
1998
View PDFchevron_right
Epstein–Barr virus latent membrane protein 1 activation of NF-κB through IRAK1 and TRAF6
章 大野
Proceedings of the National Academy of Sciences, 2003
View PDFchevron_right
Epstein-Barr virus genes and nasopharyngeal cancer
Ayse Ayhan
2006
View PDFchevron_right
Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein
George Mosialos
Proceedings of the National Academy of Sciences of the United States of America, 1996
View PDFchevron_right
Epstein--Barr Virus Gene Expression in Nasopharyngeal Carcinoma
Pierre Busson
Journal of General Virology, 1988
View PDFchevron_right
New Insights from Elucidating the Role of LMP1 in Nasopharyngeal Carcinoma
Akhil Reddy
Cancers, 2018
View PDFchevron_right
Epstein–Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKKα-dependent noncanonical NF-κB activation
Vishal Soni
Proceedings of the National Academy of Sciences, 2003
View PDFchevron_right
Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation
George Mosialos
Carolina Digital Repository (University of North Carolina at Chapel Hill), 1997
View PDFchevron_right
Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma
Pierre Busson
International Journal of Cancer, 1988
View PDFchevron_right
The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family
George Mosialos
Cell, 1995
View PDFchevron_right
Pursuing different ‘TRADDes’: TRADD signaling induced by TNF-receptor 1 and the Epstein-Barr virus oncoprotein LMP1
Arnd Kieser
Biological Chemistry, 2000
View PDFchevron_right
Regulation of Survivin and CDK4 by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cell lines
Li Li
Cell Research, 2005
View PDFchevron_right
Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK-dependent noncanonical NF-B activation
Vishal Soni
Proceedings of The National Academy of Sciences, 2004
View PDFchevron_right
The A20 Protein Interacts with the Epstein–Barr Virus Latent Membrane Protein 1 (LMP1) and Alters the LMP1/TRAF1/TRADD Complex
N. Raab-traub
Virology, 1999
View PDFchevron_right
Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF- B through a pathway that includes the NF- B-inducing kinase and the I B kinases IKK and IKK
Eudoxia Hatzivassiliou , George Mosialos
Proceedings of the National Academy of Sciences, 1998
View PDFchevron_right
Two Carboxyl-terminal Activation Regions of Epstein-Barr Virus Latent Membrane Protein 1 Activate NF-κB through Distinct Signaling Pathways in Fibroblast Cell Lines
Takeshi Nitta
Journal of Biological Chemistry, 2003
View PDFchevron_right
A novel dominant-negative mutant form of Epstein–Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways
Estelle Loing
Oncogene, 2004
View PDFchevron_right
Epstein-Barr virus-containing epithelial cells from nasopharyngeal carcinoma produce interleukin 1 alpha
Pierre Busson
Proceedings of the National Academy of Sciences, 1987
View PDFchevron_right
The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF- B
Ka-Po Tse
Proceedings of the National Academy of Sciences, 1997
View PDFchevron_right